United States Systemic Oral Azoles Market Report 2017

Name: United States Systemic Oral Azoles Market Report 2017
Brand: QYResearch
SKU: U320AAC44C4PEN
Price: 3800 USD
Availability: InStock

October 2017 | 104 pages | ID: U320AAC44C4PEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States Systemic Oral Azoles market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Systemic Oral Azoles in these regions, from 2012 to 2022 (forecast).

United States Systemic Oral Azoles market competition by top manufacturers/players, with Systemic Oral Azoles sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Novartis AG
Pfizer, Inc
Sanofi-Aventis
Merck & Co., Inc
Enzon Pharmaceuticals, Inc
Bayer AG
Astellas Pharma, Inc
GlaxoSmithKline plc
Abbott

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Fluconazole
Itraconazole
Posaconazole

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Systemic Oral Azoles for each application, including

Gastrointestinal Candidiasis
Genitourinary Tract Candidiasis
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Systemic Oral Azoles Market Report 2017

1 SYSTEMIC ORAL AZOLES OVERVIEW

1.1 Product Overview and Scope of Systemic Oral Azoles
1.2 Classification of Systemic Oral Azoles by Product Category
  1.2.1 United States Systemic Oral Azoles Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Systemic Oral Azoles Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Fluconazole
  1.2.4 Itraconazole
  1.2.5 Posaconazole
1.3 United States Systemic Oral Azoles Market by Application/End Users
  1.3.1 United States Systemic Oral Azoles Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Gastrointestinal Candidiasis
  1.3.3 Genitourinary Tract Candidiasis
  1.3.4 Other
1.4 United States Systemic Oral Azoles Market by Region
  1.4.1 United States Systemic Oral Azoles Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Systemic Oral Azoles Status and Prospect (2012-2022)
  1.4.3 Southwest Systemic Oral Azoles Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Systemic Oral Azoles Status and Prospect (2012-2022)
  1.4.5 New England Systemic Oral Azoles Status and Prospect (2012-2022)
  1.4.6 The South Systemic Oral Azoles Status and Prospect (2012-2022)
  1.4.7 The Midwest Systemic Oral Azoles Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Systemic Oral Azoles (2012-2022)
  1.5.1 United States Systemic Oral Azoles Sales and Growth Rate (2012-2022)
  1.5.2 United States Systemic Oral Azoles Revenue and Growth Rate (2012-2022)

2 UNITED STATES SYSTEMIC ORAL AZOLES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Systemic Oral Azoles Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Systemic Oral Azoles Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Systemic Oral Azoles Average Price by Players/Suppliers (2012-2017)
2.4 United States Systemic Oral Azoles Market Competitive Situation and Trends
  2.4.1 United States Systemic Oral Azoles Market Concentration Rate
  2.4.2 United States Systemic Oral Azoles Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Systemic Oral Azoles Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES SYSTEMIC ORAL AZOLES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Systemic Oral Azoles Sales and Market Share by Region (2012-2017)
3.2 United States Systemic Oral Azoles Revenue and Market Share by Region (2012-2017)
3.3 United States Systemic Oral Azoles Price by Region (2012-2017)

4 UNITED STATES SYSTEMIC ORAL AZOLES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Systemic Oral Azoles Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Systemic Oral Azoles Revenue and Market Share by Type (2012-2017)
4.3 United States Systemic Oral Azoles Price by Type (2012-2017)
4.4 United States Systemic Oral Azoles Sales Growth Rate by Type (2012-2017)

5 UNITED STATES SYSTEMIC ORAL AZOLES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Systemic Oral Azoles Sales and Market Share by Application (2012-2017)
5.2 United States Systemic Oral Azoles Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES SYSTEMIC ORAL AZOLES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis AG
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Systemic Oral Azoles Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis AG Systemic Oral Azoles Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Pfizer, Inc
  6.2.2 Systemic Oral Azoles Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer, Inc Systemic Oral Azoles Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sanofi-Aventis
  6.3.2 Systemic Oral Azoles Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sanofi-Aventis Systemic Oral Azoles Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck & Co., Inc
  6.4.2 Systemic Oral Azoles Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck & Co., Inc Systemic Oral Azoles Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Enzon Pharmaceuticals, Inc
  6.5.2 Systemic Oral Azoles Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Enzon Pharmaceuticals, Inc Systemic Oral Azoles Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Bayer AG
  6.6.2 Systemic Oral Azoles Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bayer AG Systemic Oral Azoles Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Astellas Pharma, Inc
  6.7.2 Systemic Oral Azoles Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Astellas Pharma, Inc Systemic Oral Azoles Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 GlaxoSmithKline plc
  6.8.2 Systemic Oral Azoles Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 GlaxoSmithKline plc Systemic Oral Azoles Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Abbott
  6.9.2 Systemic Oral Azoles Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Abbott Systemic Oral Azoles Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 SYSTEMIC ORAL AZOLES MANUFACTURING COST ANALYSIS

7.1 Systemic Oral Azoles Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Systemic Oral Azoles

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Systemic Oral Azoles Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Systemic Oral Azoles Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES SYSTEMIC ORAL AZOLES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Systemic Oral Azoles Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Systemic Oral Azoles Sales Volume Forecast by Type (2017-2022)
11.3 United States Systemic Oral Azoles Sales Volume Forecast by Application (2017-2022)
11.4 United States Systemic Oral Azoles Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Systemic Oral Azoles
Figure United States Systemic Oral Azoles Market Size (K Units) by Type (2012-2022)
Figure United States Systemic Oral Azoles Sales Volume Market Share by Type (Product Category) in 2016
Figure Fluconazole Product Picture
Figure Itraconazole Product Picture
Figure Posaconazole Product Picture
Figure United States Systemic Oral Azoles Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Systemic Oral Azoles by Application in 2016
Figure Gastrointestinal Candidiasis Examples
Table Key Downstream Customer in Gastrointestinal Candidiasis
Figure Genitourinary Tract Candidiasis Examples
Table Key Downstream Customer in Genitourinary Tract Candidiasis
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Systemic Oral Azoles Market Size (Million USD) by Region (2012-2022)
Figure The West Systemic Oral Azoles Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Systemic Oral Azoles Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Systemic Oral Azoles Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Systemic Oral Azoles Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Systemic Oral Azoles Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Systemic Oral Azoles Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Systemic Oral Azoles Sales (K Units) and Growth Rate (2012-2022)
Figure United States Systemic Oral Azoles Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Systemic Oral Azoles Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Systemic Oral Azoles Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Systemic Oral Azoles Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Systemic Oral Azoles Sales Share by Players/Suppliers
Figure 2017 United States Systemic Oral Azoles Sales Share by Players/Suppliers
Figure United States Systemic Oral Azoles Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Systemic Oral Azoles Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Systemic Oral Azoles Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Systemic Oral Azoles Revenue Share by Players/Suppliers
Figure 2017 United States Systemic Oral Azoles Revenue Share by Players/Suppliers
Table United States Market Systemic Oral Azoles Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Systemic Oral Azoles Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Systemic Oral Azoles Market Share of Top 3 Players/Suppliers
Figure United States Systemic Oral Azoles Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Systemic Oral Azoles Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Systemic Oral Azoles Product Category
Table United States Systemic Oral Azoles Sales (K Units) by Region (2012-2017)
Table United States Systemic Oral Azoles Sales Share by Region (2012-2017)
Figure United States Systemic Oral Azoles Sales Share by Region (2012-2017)
Figure United States Systemic Oral Azoles Sales Market Share by Region in 2016
Table United States Systemic Oral Azoles Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Systemic Oral Azoles Revenue Share by Region (2012-2017)
Figure United States Systemic Oral Azoles Revenue Market Share by Region (2012-2017)
Figure United States Systemic Oral Azoles Revenue Market Share by Region in 2016
Table United States Systemic Oral Azoles Price (USD/Unit) by Region (2012-2017)
Table United States Systemic Oral Azoles Sales (K Units) by Type (2012-2017)
Table United States Systemic Oral Azoles Sales Share by Type (2012-2017)
Figure United States Systemic Oral Azoles Sales Share by Type (2012-2017)
Figure United States Systemic Oral Azoles Sales Market Share by Type in 2016
Table United States Systemic Oral Azoles Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Systemic Oral Azoles Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Systemic Oral Azoles by Type (2012-2017)
Figure Revenue Market Share of Systemic Oral Azoles by Type in 2016
Table United States Systemic Oral Azoles Price (USD/Unit) by Types (2012-2017)
Figure United States Systemic Oral Azoles Sales Growth Rate by Type (2012-2017)
Table United States Systemic Oral Azoles Sales (K Units) by Application (2012-2017)
Table United States Systemic Oral Azoles Sales Market Share by Application (2012-2017)
Figure United States Systemic Oral Azoles Sales Market Share by Application (2012-2017)
Figure United States Systemic Oral Azoles Sales Market Share by Application in 2016
Table United States Systemic Oral Azoles Sales Growth Rate by Application (2012-2017)
Figure United States Systemic Oral Azoles Sales Growth Rate by Application (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Systemic Oral Azoles Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis AG Systemic Oral Azoles Sales Growth Rate (2012-2017)
Figure Novartis AG Systemic Oral Azoles Sales Market Share in United States (2012-2017)
Figure Novartis AG Systemic Oral Azoles Revenue Market Share in United States (2012-2017)
Table Pfizer, Inc Basic Information List
Table Pfizer, Inc Systemic Oral Azoles Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer, Inc Systemic Oral Azoles Sales Growth Rate (2012-2017)
Figure Pfizer, Inc Systemic Oral Azoles Sales Market Share in United States (2012-2017)
Figure Pfizer, Inc Systemic Oral Azoles Revenue Market Share in United States (2012-2017)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis Systemic Oral Azoles Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi-Aventis Systemic Oral Azoles Sales Growth Rate (2012-2017)
Figure Sanofi-Aventis Systemic Oral Azoles Sales Market Share in United States (2012-2017)
Figure Sanofi-Aventis Systemic Oral Azoles Revenue Market Share in United States (2012-2017)
Table Merck & Co., Inc Basic Information List
Table Merck & Co., Inc Systemic Oral Azoles Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co., Inc Systemic Oral Azoles Sales Growth Rate (2012-2017)
Figure Merck & Co., Inc Systemic Oral Azoles Sales Market Share in United States (2012-2017)
Figure Merck & Co., Inc Systemic Oral Azoles Revenue Market Share in United States (2012-2017)
Table Enzon Pharmaceuticals, Inc Basic Information List
Table Enzon Pharmaceuticals, Inc Systemic Oral Azoles Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Enzon Pharmaceuticals, Inc Systemic Oral Azoles Sales Growth Rate (2012-2017)
Figure Enzon Pharmaceuticals, Inc Systemic Oral Azoles Sales Market Share in United States (2012-2017)
Figure Enzon Pharmaceuticals, Inc Systemic Oral Azoles Revenue Market Share in United States (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Systemic Oral Azoles Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer AG Systemic Oral Azoles Sales Growth Rate (2012-2017)
Figure Bayer AG Systemic Oral Azoles Sales Market Share in United States (2012-2017)
Figure Bayer AG Systemic Oral Azoles Revenue Market Share in United States (2012-2017)
Table Astellas Pharma, Inc Basic Information List
Table Astellas Pharma, Inc Systemic Oral Azoles Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Pharma, Inc Systemic Oral Azoles Sales Growth Rate (2012-2017)
Figure Astellas Pharma, Inc Systemic Oral Azoles Sales Market Share in United States (2012-2017)
Figure Astellas Pharma, Inc Systemic Oral Azoles Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Systemic Oral Azoles Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc Systemic Oral Azoles Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline plc Systemic Oral Azoles Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline plc Systemic Oral Azoles Revenue Market Share in United States (2012-2017)
Table Abbott Basic Information List
Table Abbott Systemic Oral Azoles Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Systemic Oral Azoles Sales Growth Rate (2012-2017)
Figure Abbott Systemic Oral Azoles Sales Market Share in United States (2012-2017)
Figure Abbott Systemic Oral Azoles Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Systemic Oral Azoles
Figure Manufacturing Process Analysis of Systemic Oral Azoles
Figure Systemic Oral Azoles Industrial Chain Analysis
Table Raw Materials Sources of Systemic Oral Azoles Major Players/Suppliers in 2016
Table Major Buyers of Systemic Oral Azoles
Table Distributors/Traders List
Figure United States Systemic Oral Azoles Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Systemic Oral Azoles Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Systemic Oral Azoles Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Systemic Oral Azoles Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Systemic Oral Azoles Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Systemic Oral Azoles Sales Volume (K Units) Forecast by Type in 2022
Table United States Systemic Oral Azoles Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Systemic Oral Azoles Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Systemic Oral Azoles Sales Volume (K Units) Forecast by Application in 2022
Table United States Systemic Oral Azoles Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Systemic Oral Azoles Sales Volume Share Forecast by Region (2017-2022)
Figure United States Systemic Oral Azoles Sales Volume Share Forecast by Region (2017-2022)
Figure United States Systemic Oral Azoles Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States Systemic Oral Azoles Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports